Results of an interim analysis of a multinational randomized, double-blind, phase III study in patients (pts) with previously treated metastatic colorectal cancer (mCRC) receiving FOLFOX4 and PTK787/ZK222584 (PTK/ZK) or placebo (CONFIRM 2)

• KOEHNE C

Journal

• Proc Am Soc Clin Oncol

  Proc Am Soc Clin Oncol 2006

Details

• CRID: 1574231875336622208
• NII Article ID: 10021938761
• Data Source:
  • CiNii Articles